T-CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: drug combo trial opens
Disease control Recruiting nowThis study is for adults with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma that has come back or not responded to treatment. Researchers are adding a new drug, capivasertib, to a standard chemotherapy and venetoclax regimen to see if it is safe and works better. T…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Promising drug cocktail targets tough blood cancers in kids
Disease control Recruiting nowThis study tests whether a combination of three drugs—calaspargase pegol-mknl, decitabine, and venetoclax—can help control relapsed or treatment-resistant T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy) in patients aged 1 month to 21 years. T…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Engineered immune cells target tough blood cancers in early trial
Disease control Recruiting nowThis early-phase trial tests whether a new type of CAR T-cell therapy, made from a patient's own blood cells, is safe for children and adults with T cell leukemia or lymphoma that has come back or not responded to standard treatments. Participants receive a short course of chemot…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New trial aims to boost survival in kids with rare lymphoma
Disease control Recruiting nowThis study compares two different ways of giving methotrexate (a chemotherapy drug) to children and teens newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer of the immune system. About 200 participants will be randomly assigned to one of two treatment plans to see …
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC